Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06530693 · ClinicalTrials.gov registry record · NA
Optimizing the Prehospital Use of Stroke Systems of Care-Reacting to Changing Paradigms-Implementation (OPUS-i)
A NA study of Stroke, sponsored by Temple University.
- Recruiting
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 2
- Study locations
NCT06530693: Recruiting NA study of Stroke, sponsored by Temple University.
NCT06530693 is a NA study of Stroke that is actively recruiting participants, run by Temple University. The registered enrollment target is 360 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06530693, a NA study of Stroke, is actively recruiting participants, sponsored by Temple University.
- RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 2
- Study locations
Study Summary
This interventional trial will compare a novel prehospital stroke transport algorithm (OPUS-i) to a traditional prehospital stroke transport algorithm to improve outcomes in rural stroke patients by determining the effect of implementing a data-driven prehospital stroke algorithm on time to and endovascular therapy. The study consists of a multicenter cohort and will last 24 months but individual subject study duration is 90 days.
Primary Outcome
This outcome will assess process measures for acute stroke patients
Conditions Studied
Interventions
- OTHER OPUS-i algorithm
Study Locations (2)
New Jersey
- Cooper University Health - Camden
Pennsylvania
- 3401 N Broad street - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2027-09 |
| Phase | NA |
What NCT06530693 shows while recruiting
NCT06530693 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which OPUS-i algorithm is the first listed.
NCT06530693 reports a single indexed study location in New Jersey, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06530693 about?
NCT06530693 is a clinical study titled "Optimizing the Prehospital Use of Stroke Systems of Care-Reacting to Changing Paradigms-Implementation (OPUS-i)". This interventional trial will compare a novel prehospital stroke transport algorithm (OPUS-i) to a traditional prehospital stroke transport algorithm to improve outcomes in rural stroke patients by determining the effect of implementing a data-driven prehospital stroke algorithm on time to and endo...
What is the current status of trial NCT06530693?
This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2025-04-01. Estimated completion is 2027-09.
What conditions does trial NCT06530693 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT06530693?
The interventions under investigation include: OPUS-i algorithm (OTHER).
Who is sponsoring clinical trial NCT06530693?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06530693 being conducted?
This trial has 2 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06530693's enrollment target sits among peer trials
360 69th of 454 higher than 386 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI